First Manhattan’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $371K | Sell |
661
-1,510
| -70% | -$968K | ﹤0.01% | 623 |
|
|
2025
Q4 | $1.47M | Buy |
2,171
+1,266
| +140% | +$862K | ﹤0.01% | 380 |
|
|
2025
Q3 | $578K | Hold |
905
| – | – | ﹤0.01% | 518 |
|
|
2025
Q2 | $485K | Hold |
905
| – | – | ﹤0.01% | 540 |
|
|
2025
Q1 | $380K | Hold |
905
| – | – | ﹤0.01% | 552 |
|
|
2024
Q4 | $374K | Sell |
905
-10
| -1% | -$4.39K | ﹤0.01% | 559 |
|
|
2024
Q3 | $462K | Hold |
915
| – | – | ﹤0.01% | 508 |
|
|
2024
Q2 | $446K | Sell |
915
-460
| -33% | -$231K | ﹤0.01% | 492 |
|
|
2024
Q1 | $742K | Hold |
1,375
| – | – | ﹤0.01% | 418 |
|
|
2023
Q4 | $763K | Buy |
1,375
+920
| +202% | +$432K | ﹤0.01% | 414 |
|
|
2023
Q3 | $199K | Hold |
455
| – | – | ﹤0.01% | 658 |
|
|
2023
Q2 | $229K | Sell |
455
-36,430
| -99% | -$17.5M | ﹤0.01% | 635 |
|
|
2023
Q1 | $18.4M | Sell |
36,885
-9
| -0% | -$4.31K | 0.07% | 102 |
|
|
2022
Q4 | $15.1M | Sell |
36,894
-532
| -1% | -$207K | 0.06% | 117 |
|
|
2022
Q3 | $12.2M | Hold |
37,426
| – | – | 0.05% | 125 |
|
|
2022
Q2 | $13.1M | Hold |
37,426
| – | – | 0.05% | 128 |
|
|
2022
Q1 | $20.5M | Sell |
37,426
-2
| -0% | -$1.05K | 0.07% | 111 |
|
|
2021
Q4 | $24.6M | Sell |
37,428
-377
| -1% | -$237K | 0.08% | 102 |
|
|
2021
Q3 | $23.5M | Sell |
37,805
-1,050
| -3% | -$706K | 0.09% | 101 |
|
|
2021
Q2 | $24.5M | Hold |
38,855
| – | – | 0.09% | 105 |
|
|
2021
Q1 | $19M | Buy |
38,855
+30
| +0.1% | +$15K | 0.08% | 112 |
|
|
2020
Q4 | $19.4M | Sell |
38,825
-350
| -0.9% | -$157K | 0.09% | 104 |
|
|
2020
Q3 | $15.4M | Sell |
39,175
-1,611
| -4% | -$596K | 0.08% | 112 |
|
|
2020
Q2 | $13.5M | Hold |
40,786
| – | – | 0.08% | 121 |
|
|
2020
Q1 | $9.88M | Sell |
40,786
-716
| -2% | -$187K | 0.06% | 148 |
|
|
2019
Q4 | $10.8M | Hold |
41,502
| – | – | 0.05% | 159 |
|
|
2019
Q3 | $11.3M | Sell |
41,502
-84
| -0.2% | -$23.4K | 0.06% | 156 |
|
|
2019
Q2 | $11.4M | Buy |
41,586
+37,461
| +908% | +$9.23M | 0.06% | 152 |
|
|
2019
Q1 | $922K | Hold |
4,125
| – | – | 0.01% | 445 |
|
|
2018
Q4 | $767K | Hold |
4,125
| – | – | ﹤0.01% | 473 |
|
|
2018
Q3 | $1.03M | Buy |
4,125
+75
| +2% | +$18.2K | 0.01% | 456 |
|
|
2018
Q2 | $882K | Hold |
4,050
| – | – | 0.01% | 464 |
|
|
2018
Q1 | $775K | Hold |
4,050
| – | – | ﹤0.01% | 468 |
|
|
2017
Q4 | $633K | Hold |
4,050
| – | – | ﹤0.01% | 514 |
|
|
2017
Q3 | $629K | Hold |
4,050
| – | – | ﹤0.01% | 505 |
|
|
2017
Q2 | $653K | Hold |
4,050
| – | – | ﹤0.01% | 494 |
|
|
2017
Q1 | $626K | Hold |
4,050
| – | – | ﹤0.01% | 485 |
|
|
2016
Q4 | $474K | Buy |
4,050
+650
| +19% | +$74.2K | ﹤0.01% | 514 |
|
|
2016
Q3 | $383K | Sell |
3,400
-122
| -3% | -$12.9K | ﹤0.01% | 554 |
|
|
2016
Q2 | $327K | Hold |
3,522
| – | – | ﹤0.01% | 581 |
|
|
2016
Q1 | $275K | Buy |
3,522
+3,400
| +2,787% | +$245K | ﹤0.01% | 612 |
|
|
2015
Q4 | $8K | Hold |
122
| – | – | ﹤0.01% | 1209 |
|
|
2015
Q3 | $9K | Sell |
122
-56,440
| -100% | -$4.04M | ﹤0.01% | 1200 |
|
|
2015
Q2 | $3.63M | Hold |
56,562
| – | – | 0.02% | 287 |
|
|
2015
Q1 | $4.37M | Hold |
56,562
| – | – | 0.03% | 262 |
|
|
2014
Q4 | $4.19M | Buy |
56,562
+534
| +1% | +$37.4K | 0.02% | 270 |
|
|
2014
Q3 | $3.3M | Hold |
56,028
| – | – | 0.02% | 297 |
|
|
2014
Q2 | $3.74M | Hold |
56,028
| – | – | 0.02% | 278 |
|
|
2014
Q1 | $3.4M | Buy |
+56,028
| New | +$3.34M | 0.02% | 286 |
|
Other funds holding IDXX
VCM
VPM
First Manhattan's IDXX Position: Q1 2026 in Review
First Manhattan reduced its Idexx Laboratories (IDXX) stake by 70% in Q1 2026, selling an estimated $968K and leaving 661 shares worth $371K. The position accounts for ﹤0.01% of the portfolio, ranked #623.
First Manhattan first reported a position in IDXX in Q1 2014 and has held it in 49 quarters since. The position peaked at $24.6M in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- First Manhattan held 661 shares of Idexx Laboratories worth $371K as of Q1 2026.
- First Manhattan sold 1,510 Idexx Laboratories shares in Q1 2026, an estimated $968K.
- Idexx Laboratories made up ﹤0.01% of First Manhattan's portfolio in Q1 2026, its #623 holding.
- First Manhattan first reported a position in Idexx Laboratories in Q1 2014 and has held it in 49 quarters since.
- First Manhattan's Idexx Laboratories position peaked at $24.6M in Q4 2021.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.